documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
81 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2009 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_end_date, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-N-0665-0077 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor; Isoflurane | Rule | Final Rule | 2009-12-28T05:00:00Z | 2009 | 12 | 2013-07-09T18:25:09Z | E9-30590 | 0 | 0 | 0900006480a72080 | ||
| FDA-2009-N-0665-0076 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs: Polysulfated Glycosaminoglycan | Rule | Final Rule | 2009-12-21T05:00:00Z | 2009 | 12 | 2013-07-09T15:52:49Z | E9-30222 | 0 | 0 | 0900006480a6eff2 | ||
| FDA-2009-N-0665-0068 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs; Insulin - Final Rule | Rule | Final Rule | 2009-12-14T05:00:00Z | 2009 | 12 | 2014-01-08T13:27:08Z | E9-29583 | 0 | 0 | 0900006480a6a16d | ||
| FDA-2009-N-0665-0070 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2009-12-14T05:00:00Z | 2009 | 12 | 2013-07-09T18:26:32Z | E9-29627 | 0 | 0 | 0900006480a6a16e | ||
| FDA-2009-N-0665-0065 | FDA | FDA-2009-N-0665 | Oral Dosage Form New Animal Drugs: Chlortetracycline Powder - Final Rule | Rule | Final Rule | 2009-11-30T05:00:00Z | 2009 | 11 | 2014-01-08T12:45:23Z | E9-28468 | 0 | 0 | 0900006480a60309 | ||
| FDA-2009-N-0665-0064 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2009-11-25T05:00:00Z | 2009 | 11 | 2009-11-25T05:00:00Z | 2013-07-09T18:28:15Z | E9-28217 | 0 | 0 | 0900006480a5e995 | |
| FDA-1977-N-0013-0041 | FDA | Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN FDA-1977-N-0013 | Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment | Rule | Final Rule | 2009-11-25T05:00:00Z | 2009 | 11 | 2009-11-25T05:00:00Z | 2019-02-22T12:55:02Z | E9-28296 | 0 | 0 | 0900006480a5e8d7 | |
| FDA-2009-N-0665-0061 | FDA | FDA-2009-N-0665 | New Animal Drugs for Use in Animal Feeds; Melengestrol; Monensin; Tylosin | Rule | Final Rule | 2009-11-23T05:00:00Z | 2009 | 11 | 2013-07-09T18:06:51Z | E9-28019 | 0 | 0 | 0900006480a5c836 | ||
| FDA-2009-N-0665-0063 | FDA | FDA-2009-N-0665 | New Animal Drugs for Use in Animal Feeds; Change of Sponsor | Rule | Final Rule | 2009-11-23T05:00:00Z | 2009 | 11 | 2013-07-09T18:45:41Z | E9-28009 | 0 | 0 | 0900006480a5cd02 | ||
| FDA-2009-N-0665-0055 | FDA | FDA-2009-N-0665 | Certain Other Dosage Form New Animal Drugs; Progesterone Intravaginal Inserts | Rule | Final Rule | 2009-11-17T05:00:00Z | 2009 | 11 | 2013-07-09T14:49:52Z | E9-27497 | 0 | 0 | 0900006480a592c7 | ||
| FDA-2007-C-0456-0002 | FDA | FDA-2007-C-0456 | Listing of Color Additives Exempt From Certification; Paracoccus Pigment | Rule | NFR-Notice of Final Rule | 2009-11-16T05:00:00Z | 2009 | 11 | 2009-11-16T05:00:00Z | 2009-12-17T04:59:59Z | 2026-01-02T23:03:56Z | E9-27394 | 0 | 0 | 0900006480a582d1 |
| FDA-2009-N-0666-0003 | FDA | FDA-2009-N-0666 | New Animal Drugs in Genetically Engineered Animals | Rule | CFR-Correction | 2009-11-12T05:00:00Z | 2009 | 11 | 2009-11-12T05:00:00Z | 2009-11-12T14:55:34Z | E9-27305 | 0 | 0 | 0900006480a5600f | |
| FDA-2009-N-0464-0001 | FDA | FDA-2009-N-0464 | Investigational New Drug Applications; Technical Amendment | Rule | NFR-Notice of Final Rule | 2009-10-29T04:00:00Z | 2009 | 10 | 2009-10-29T18:43:42Z | E9-26095 | 0 | 0 | 0900006480a4d85f | ||
| FDA-2009-N-0472-0001 | FDA | FDA-2009-N-0472 | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Cardiac Allograft | Rule | NFR-Notice of Final Rule | 2009-10-21T04:00:00Z | 2009 | 10 | 2009-10-21T04:00:00Z | 2009-10-21T20:51:55Z | E9-25315 | 0 | 0 | 0900006480a47214 | |
| FDA-1977-N-0225-0001 | FDA | Polychlorinated Biphenyls- RETIRED FDA-1977-N-0225 | Polychlorinated Biphenyls (PCB's) | Rule | Final Rule | 2009-09-25T04:00:00Z | 2009 | 9 | 2020-04-28T12:20:16Z | 77-7519 | 0 | 0 | 09000064805ecf64 | ||
| FDA-2009-N-0665-0047 | FDA | FDA-2009-N-0665 | Ophthalmic and Topical Dosage Form New Animal Drugs; Diclofenac | Rule | Final Rule | 2009-09-16T04:00:00Z | 2009 | 9 | 2009-09-16T04:00:00Z | 2013-07-09T16:18:44Z | E9-22292 | 0 | 0 | 0900006480a2469d | |
| FDA-1979-N-0319-0003 | FDA | Sodium Stearoyl-2-Lactylate FDA-1979-N-0319 | Part 172-- Food Additives Permitted for Direct Addition to Food for Human Consumption; Sodium Stearoyl-2-Lactylate | Rule | Final Rule | 2009-08-31T04:00:00Z | 2009 | 8 | 2009-08-31T04:00:00Z | 1980-09-06T03:59:59Z | 2019-06-27T12:23:27Z | 80-23303 | 0 | 0 | 0900006480555c16 |
| FDA-1993-P-0085-0004 | FDA | Permit the Term "DATEM" on Food Labels FDA-1993-P-0085 | Diacetyl Tartaric Acid Esters of Mono-and Diglycerides; Revision of Common or Usual Name | Rule | NFR-Notice of Final Rule | 2009-08-28T04:00:00Z | 2009 | 8 | 2009-08-28T04:00:00Z | 2009-08-29T01:58:50Z | 0 | 0 | 09000064804fd4e5 | ||
| FDA-2009-N-0381-0001 | FDA | FDA-2009-N-0381 | Advisory Committee; Tobacco Products Scientific Advisory Committee; Establishment | Rule | NFR-Notice of Final Rule | 2009-08-26T04:00:00Z | 2009 | 8 | 2009-08-26T04:00:00Z | 2009-08-26T16:21:49Z | E9-20485 | 0 | 0 | 0900006480a12f27 | |
| FDA-2008-N-0176-0009 | FDA | FDA-2008-N-0176 | Defining "Small Number of Animals" for Minor Use Designation | Rule | NFR-Notice of Final Rule | 2009-08-26T04:00:00Z | 2009 | 8 | 2009-08-26T04:00:00Z | 2011-06-11T16:27:43Z | E9-20553 | 0 | 0 | 0900006480a12f05 | |
| FDA-2009-N-0344-0002 | FDA | FDA-2009-N-0344 | Microbiology Devices; Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays | Rule | NFR-Notice of Final Rule | 2009-08-25T04:00:00Z | 2009 | 8 | 2009-08-25T04:00:00Z | 2009-11-10T04:59:59Z | 2009-08-25T17:11:12Z | E9-20411 | 0 | 0 | 0900006480a11be7 |
| FDA-2009-N-0100-0003 | FDA | FDA-2009-N-0100 | Revision of the Requirements for Publication of License Revocation; Confirmation of Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2009-08-21T04:00:00Z | 2009 | 8 | 2009-08-21T16:34:42Z | E9-20119 | 0 | 0 | 0900006480a0f501 | ||
| FDA-2009-N-0665-0045 | FDA | FDA-2009-N-0665 | New Animal Drugs for Use in Animal Feeds: Semduramicin; Virginiamycin | Rule | Final Rule | 2009-08-18T04:00:00Z | 2009 | 8 | 2013-07-09T16:26:50Z | E9-19738 | 0 | 0 | 0900006480a0c245 | ||
| FDA-2006-N-0238-0026 | FDA | Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 | Expanded Access to Investigational Drugs for Treatment Use | Rule | NFR-Notice of Final Rule | 2009-08-13T04:00:00Z | 2009 | 8 | 2009-08-13T04:00:00Z | 2015-06-02T18:01:51Z | E9-19005 | 0 | 0 | 0900006480a084e7 | |
| FDA-2009-N-0665-0044 | FDA | FDA-2009-N-0665 | New Animal Drugs for Use in Animal Feeds: Oxytetracycline; Neomycin | Rule | Final Rule | 2009-08-13T04:00:00Z | 2009 | 8 | 2009-08-13T04:00:00Z | 2013-07-09T18:03:19Z | E9-19414 | 0 | 0 | 0900006480a08523 | |
| FDA-2006-N-0237-0049 | FDA | Charging for Investigational Drugs Treatment Use FDA-2006-N-0237 | Notice of Final Rule re Charging for Investigational Drugs Under an Investigational New Drug Application | Rule | Final Rule | 2009-08-13T04:00:00Z | 2009 | 8 | 2009-08-13T04:00:00Z | 2016-02-09T20:59:52Z | E9-19004 | 0 | 0 | 0900006480a08453 | |
| FDA-2009-N-0666-0002 | FDA | FDA-2009-N-0666 | Use of Ozone-Depleting Substances; Epinephrine; CFR Correction | Rule | NCR-Notice of Correction | 2009-08-11T04:00:00Z | 2009 | 8 | 2009-08-11T17:57:32Z | E9-19297 | 0 | 0 | 0900006480a05856 | ||
| FDA-2008-N-0163-0250 | FDA | FDA-2008-N-0163 | Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury, Designation of Special Controls for Dental Amalgam, Mercury, and Amalgam Alloy; Final Rule | Rule | NFR-Notice of Final Rule | 2009-08-04T04:00:00Z | 2009 | 8 | 2009-08-04T04:00:00Z | 2011-06-11T16:27:42Z | E9-18447 | 0 | 0 | 0900006480a00973 | |
| FDA-2008-N-0163-0249 | FDA | FDA-2008-N-0163 | Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury, Designation of Special Controls for Dental Amalgam, Mercury, and Amalgam Alloy | Rule | 2009-08-04T00:00:00Z | 2009 | 8 | 2011-06-11T16:27:42Z | 0 | 1 | 0900006480a007e1 | ||||
| FDA-2009-N-0665-0042 | FDA | FDA-2009-N-0665 | New Animal Drugs: Nitrofurazone Ointment - Final Rule | Rule | Final Rule | 2009-08-03T04:00:00Z | 2009 | 8 | 2009-08-03T04:00:00Z | 2014-01-08T12:47:59Z | E9-18337 | 0 | 0 | 09000064809ffeea | |
| FDA-2008-N-0341-0006 | FDA | FDA-2008-N-0341 | Applications for Food and Drug Administration Approval To Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs | Rule | NFR-Notice of Final Rule | 2009-07-28T04:00:00Z | 2009 | 7 | 2009-07-28T04:00:00Z | 2011-06-11T16:27:46Z | E9-17963 | 0 | 0 | 09000064809fc2ed | |
| FDA-2009-N-0316-0001 | FDA | FDA-2009-N-0316 | New Drug Applications and Abbreviated New Drug Applications; Technical Amendment | Rule | NFR-Notice of Final Rule | 2009-07-24T04:00:00Z | 2009 | 7 | 2009-07-24T04:00:00Z | 2009-07-24T14:27:40Z | E9-17680 | 0 | 0 | 09000064809fa1ef | |
| FDA-2009-N-0270-0001 | FDA | FDA-2009-N-0270 | Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications | Rule | NFR-Notice of Final Rule | 2009-07-22T04:00:00Z | 2009 | 7 | 2009-07-22T04:00:00Z | 2009-07-22T16:14:22Z | E9-17409 | 0 | 0 | 09000064809f7d5a | |
| FDA-2009-N-0665-0041 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2009-07-22T04:00:00Z | 2009 | 7 | 2009-07-22T04:00:00Z | 2013-07-09T18:39:29Z | E9-17356 | 0 | 0 | 09000064809f783c | |
| FDA-2009-N-0310-0001 | FDA | FDA-2009-N-0310 | Advisory Committee; Risk Communication Advisory Committee; Termination and Recharter | Rule | NFR-Notice of Final Rule | 2009-07-21T04:00:00Z | 2009 | 7 | 2009-07-21T04:00:00Z | 2009-07-21T16:40:59Z | E9-17218 | 0 | 0 | 09000064809f722e | |
| FDA-1995-F-0403-0002 | FDA | Safe Use of Peroxyacetic,Acetic & Hydrogen peroxide Acids FDA-1995-F-0403 | Secondary Direct Food Additives Permitted in Food for Human Consumption | Rule | NFR-Notice of Final Rule | 2009-07-20T04:00:00Z | 2009 | 7 | 2009-07-20T04:00:00Z | 1996-10-04T03:59:59Z | 2009-07-22T02:57:56Z | 0 | 0 | 090000648059aeba | |
| FDA-2009-N-0665-0035 | FDA | FDA-2009-N-0665 | New Animal Drugs; Ceftiofur Sodium - Final Rule | Rule | Final Rule | 2009-07-15T04:00:00Z | 2009 | 7 | 2009-07-15T04:00:00Z | 2014-01-08T12:49:23Z | E9-16734 | 0 | 0 | 09000064809f1cf3 | |
| FDA-2009-N-0665-0039 | FDA | FDA-2009-N-0665 | New Animal Drugs for Use in Animal Feeds; Lasalocid; Roxarsone | Rule | Final Rule | 2009-07-15T04:00:00Z | 2009 | 7 | 2009-07-15T04:00:00Z | 2013-07-09T14:20:50Z | E9-16733 | 0 | 0 | 09000064809f1daf | |
| FDA-2009-N-0665-0037 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs; Flunixin - Final Rule | Rule | Final Rule | 2009-07-15T04:00:00Z | 2009 | 7 | 2009-07-15T04:00:00Z | 2014-01-07T21:46:03Z | E9-16735 | 0 | 0 | 09000064809f1d64 | |
| FDA-2000-N-0190-0018 | FDA | Egg Safety Action Plan FDA-2000-N-0190 | Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation | Rule | NFR-Notice of Final Rule | 2009-07-09T04:00:00Z | 2009 | 7 | 2009-07-09T04:00:00Z | 2011-06-11T16:25:52Z | E9-16119 | 0 | 0 | 09000064809ed1eb | |
| FDA-1977-N-0013-0037 | FDA | Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN FDA-1977-N-0013 | Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph; Corrections | Rule | Correction | 2009-06-30T04:00:00Z | 2009 | 6 | 2009-06-30T04:00:00Z | 2019-02-21T21:46:48Z | E9-15403 | 0 | 0 | 09000064809e636f | |
| FDA-1991-E-0155-0002 | FDA | Floxin; Patent Extension Application No. 4,382,892 FDA-1991-E-0155 | U.S. Patent and Trademark Office to Louis Gubinsky (Sughrue, Mion, Zinn, MacPeak & Seas) - Certificate Extending Patent Term | Rule | Certificate Extending Patent Term | 2009-06-26T04:00:00Z | 2009 | 6 | 2009-06-26T04:00:00Z | 2023-07-24T19:25:47Z | 0 | 0 | 090000648052d1ed | ||
| FDA-1989-F-0343-0002 | FDA | Safe Use Of Sucrose Fatty Acid Esters-CLOSED FDA-1989-F-0343 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Sucrose Fatty Acid Esters | Rule | Final Rule | 2009-06-19T04:00:00Z | 2009 | 6 | 2009-06-19T04:00:00Z | 1995-09-29T03:59:59Z | 2023-12-29T13:54:30Z | 0 | 0 | 0900006480479f36 | |
| FDA-1989-F-0333-0002 | FDA | Safe use of Sucrose Fatty Acid Esters FDA-1989-F-0333 | Food Additives Permitted for Direct Addition to Food fo Human Consumption; Sucrose Fatty Acid Esters | Rule | NFR-Notice of Final Rule | 2009-06-19T04:00:00Z | 2009 | 6 | 2009-06-19T04:00:00Z | 1995-09-29T03:59:59Z | 2009-06-19T23:40:56Z | 0 | 0 | 0900006480479ebe | |
| FDA-1992-F-0213-0002 | FDA | Safe use of Sucrose Fatty Acid Esters FDA-1992-F-0213 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Sucrose Fatty Acid Esters | Rule | NFR-Notice of Final Rule | 2009-06-19T04:00:00Z | 2009 | 6 | 2009-06-19T04:00:00Z | 1995-09-29T03:59:59Z | 2009-06-19T23:20:54Z | 0 | 0 | 090000648052fa1d | |
| FDA-2009-N-0665-0030 | FDA | FDA-2009-N-0665 | Oral Dosage Form New Animal Drugs; Toceranib - Final Rule | Rule | Final Rule | 2009-06-18T04:00:00Z | 2009 | 6 | 2009-06-18T04:00:00Z | 2014-01-08T13:24:48Z | E9-14299 | 0 | 0 | 09000064809d24c0 | |
| FDA-2009-N-0665-0029 | FDA | FDA-2009-N-0665 | New Animal Drugs for Use in Animal Feeds; Chlortetracycline | Rule | Final Rule | 2009-06-12T04:00:00Z | 2009 | 6 | 2009-06-12T04:00:00Z | 2013-07-09T18:20:51Z | E9-13849 | 0 | 0 | 09000064809cdaa9 | |
| FDA-2009-N-0665-0027 | FDA | FDA-2009-N-0665 | Oral Dosage Form New Animal Drugs: Methimazole - Final Rule | Rule | Final Rule | 2009-06-11T04:00:00Z | 2009 | 6 | 2009-06-11T04:00:00Z | 2014-01-08T13:12:43Z | E9-13685 | 0 | 0 | 09000064809cc342 | |
| FDA-2009-N-0665-0026 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor; Fomepizole | Rule | Final Rule | 2009-06-05T04:00:00Z | 2009 | 6 | 2009-06-05T04:00:00Z | 2013-07-09T15:59:42Z | E9-13126 | 0 | 0 | 09000064809c67a5 | |
| FDA-2009-N-0665-0025 | FDA | FDA-2009-N-0665 | Ophthalmic and Topical Dosage Form New Animal Drugs; Change of Sponsor; Diclofenac; Ivermectin Otic Suspension - Final Rule | Rule | Final Rule | 2009-06-04T04:00:00Z | 2009 | 6 | 2009-06-04T04:00:00Z | 2014-01-08T13:44:43Z | E9-13015 | 0 | 0 | 09000064809c4ae9 | |
| FDA-2008-N-0446-0016 | FDA | FDA-2008-N-0446 | Beverages: Bottled Water | Rule | NFR-Notice of Final Rule | 2009-05-29T04:00:00Z | 2009 | 5 | 2009-05-29T04:00:00Z | 2009-05-29T15:29:41Z | E9-12494 | 0 | 0 | 09000064809be76c | |
| FDA-2009-N-0665-0024 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Luprostiol | Rule | Final Rule | 2009-05-27T04:00:00Z | 2009 | 5 | 2009-05-27T04:00:00Z | 2013-07-09T17:58:46Z | E9-12269 | 0 | 0 | 09000064809b8f02 | |
| FDA-1991-E-0282-0004 | FDA | Pravachol; Patent Extension Application 4,346,227 FDA-1991-E-0282 | U.S. Patent and Trademark Office - Certificate Extending Patent | Rule | CEP-Certificate Extending Patent Term | 2009-05-14T04:00:00Z | 2009 | 5 | 2009-05-14T04:00:00Z | 2009-05-14T21:35:17Z | 0 | 0 | 090000648052fa55 | ||
| FDA-2009-N-0665-0019 | FDA | FDA-2009-N-0665 | New Animal Drugs: Trilostane - Final Rule | Rule | Final Rule | 2009-05-11T04:00:00Z | 2009 | 5 | 2009-05-11T04:00:00Z | 2014-01-08T13:14:27Z | E9-10927 | 0 | 0 | 0900006480987dc5 | |
| FDA-2009-N-0665-0018 | FDA | FDA-2009-N-0665 | New Animal Drugs: Carprofen - Final Rule | Rule | Final Rule | 2009-05-11T04:00:00Z | 2009 | 5 | 2009-05-11T04:00:00Z | 2014-01-07T21:42:40Z | E9-10925 | 0 | 0 | 0900006480987da1 | |
| FDA-2009-N-0665-0016 | FDA | FDA-2009-N-0665 | New Animal Drugs; Change of Sponsor | Rule | NFR-Notice of Final Rule | 2009-05-05T04:00:00Z | 2009 | 5 | 2009-05-05T04:00:00Z | 2009-05-05T16:02:55Z | E9-10262 | 0 | 0 | 0900006480975f81 | |
| FDA-2009-N-0665-0017 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage From New Animal Drugs; Change of Sponsor; Repository Corticotropin Injection | Rule | Final Rule | 2009-05-05T04:00:00Z | 2009 | 5 | 2009-05-05T04:00:00Z | 2013-07-09T18:36:17Z | E9-10291 | 0 | 0 | 0900006480975fc4 | |
| FDA-2002-N-0031-0398 | FDA | Animal Proteins Prohibited in Ruminant Feed FDA-2002-N-0031 | Substances Prohibited From Use in Animal Food or Feed; Confirmation of Effective Date of Final Rule; Correction | Rule | NCR-Notice of Correction | 2009-05-05T04:00:00Z | 2009 | 5 | 2009-05-05T04:00:00Z | 2011-06-11T16:25:52Z | E9-10138 | 0 | 0 | 0900006480975fcc | |
| FDA-2009-N-0100-0001 | FDA | FDA-2009-N-0100 | Revision of the Requirements for Publication of License Revocation | Rule | NFR-Notice of Final Rule | 2009-05-05T04:00:00Z | 2009 | 5 | 2009-05-05T04:00:00Z | 2009-07-21T03:59:59Z | 2009-05-05T15:50:19Z | E9-10244 | 0 | 0 | 0900006480975f36 |
| FDA-2009-N-0665-0015 | FDA | FDA-2009-N-0665 | Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin | Rule | Final Rule | 2009-04-30T04:00:00Z | 2009 | 4 | 2009-04-30T04:00:00Z | 2013-07-09T16:13:59Z | E9-09901 | 0 | 0 | 090000648096fd38 | |
| FDA-1977-N-0013-0017 | FDA | Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN FDA-1977-N-0013 | Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph | Rule | Final Rule | 2009-04-29T04:00:00Z | 2009 | 4 | 2009-04-29T04:00:00Z | 2019-03-20T19:57:29Z | E9-9684 | 0 | 0 | 090000648096ef53 | |
| FDA-2009-N-0665-0014 | FDA | FDA-2009-N-0665 | Intramammary Dosage Forms: Change of Sponsor, | Rule | Final Rule | 2009-04-27T04:00:00Z | 2009 | 4 | 2009-04-27T04:00:00Z | 2013-07-09T18:31:07Z | E9-09527 | 0 | 0 | 090000648096d22e | |
| FDA-2002-N-0031-0397 | FDA | Animal Proteins Prohibited in Ruminant Feed FDA-2002-N-0031 | Substances Prohibited From Use in Animal Food or Feed; Confirmation of Effective Date of Final Rule | Rule | NCD-Notice of Confirmation of Effective Date | 2009-04-24T04:00:00Z | 2009 | 4 | 2011-06-11T16:25:53Z | E9-09466 | 0 | 0 | 0900006480968c71 | ||
| FDA-2009-N-0144-0001 | FDA | FDA-2009-N-0144 | Revision of Organization and Conforming Changes to Regulations | Rule | NIR-Notice of Interim Rule | 2009-04-01T04:00:00Z | 2009 | 4 | 2009-04-01T04:00:00Z | 2009-04-01T18:38:04Z | E9-07349 | 0 | 0 | 090000648093b13b | |
| FDA-2009-N-0141-0001 | FDA | FDA-2009-N-0141 | Medical Devices; Technical Amendment | Rule | NFR-Notice of Final Rule | 2009-03-31T04:00:00Z | 2009 | 3 | 2009-03-31T04:00:00Z | 2009-03-31T16:58:22Z | E9-07073 | 0 | 0 | 0900006480939356 | |
| FDA-2009-N-0666-0001 | FDA | FDA-2009-N-0666 | New Animal Drugs for Use in Animal Feeds; CFR Correction | Rule | CFR-Correction | 2009-03-26T04:00:00Z | 2009 | 3 | 2009-03-26T18:02:55Z | E9-06810 | 0 | 0 | 09000064809306b9 | ||
| FDA-2005-F-0505-0002 | FDA | provide for the safe use of a mixture of hydrogen peroxide, silver nitrate, phosphoric acid, tartaric acid, glutamic acid, and sodium tripolyphosphate as an antimicrobial agent in bottled drinking water (FAP 5A4759) FDA-2005-F-0505 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Silver Nitrate and Hydrogen Peroxide | Rule | Final Rule | 2009-03-18T04:00:00Z | 2009 | 3 | 2009-03-18T04:00:00Z | 2009-04-18T03:59:59Z | 2025-11-26T20:21:30Z | E9-05852 | 0 | 0 | 090000648091b633 |
| FDA-2007-F-0274-0002 | FDA | FDA-2007-F-0274 | Food Additives Permitted for Direct Addition to Food for Human Consumption: Vitamin D | Rule | NFR-Notice of Final Rule | 2009-03-16T04:00:00Z | 2009 | 3 | 2009-03-16T04:00:00Z | 2009-04-16T03:59:59Z | 2026-01-03T00:14:06Z | E9-05549 | 0 | 0 | 09000064809146e6 |
| FDA-1998-P-0032-0006 | FDA | Prohibition of Cochineal Extract and Carmine Color Additives - CLOSED FDA-1998-P-0032 | Listing of Color Additives Exempt From Certification; Food, Drug, and Cosmetic Labeling: Cochineal Extract and Carmine Declaration; Confirmation of Effective Date | Rule | Confirmation of Effective Date | 2009-03-11T04:00:00Z | 2009 | 3 | 2009-03-11T04:00:00Z | 2016-03-21T17:25:55Z | E9-05286 | 0 | 0 | 090000648090520b | |
| FDA-2009-N-0665-0009 | FDA | FDA-2009-N-0665 | Other Dosage Form New Animal Drugs: Sevoflurane | Rule | Final Rule | 2009-03-11T04:00:00Z | 2009 | 3 | 2009-03-11T04:00:00Z | 2013-07-09T16:13:07Z | E9-04879 | 0 | 0 | 090000648090506a | |
| FDA-2009-N-0665-0010 | FDA | FDA-2009-N-0665 | Oral Dosage Form New Animal Drugs: Amprolium - Final Rule | Rule | Final Rule | 2009-03-11T04:00:00Z | 2009 | 3 | 2009-03-11T04:00:00Z | 2014-01-07T21:51:09Z | E9-05131 | 0 | 0 | 09000064809050a7 | |
| FDA-2009-N-0665-0006 | FDA | FDA-2009-N-0665 | Implantation or Injectable Dosage Form New Animal Drugs; Ivermectin - Final Rule | Rule | Final Rule | 2009-03-02T05:00:00Z | 2009 | 3 | 2009-03-02T05:00:00Z | 2014-01-08T13:47:58Z | E9-04304 | 0 | 0 | 09000064808e61ca | |
| FDA-2008-N-0561-0004 | FDA | FDA-2008-N-0561 | Maximum Civil Money Penalty Amounts and Compliance, etc.: Confirmation of Effective Date | Rule | NFR-Notice of Final Rule | 2009-02-24T05:00:00Z | 2009 | 2 | 2009-02-24T05:00:00Z | 2009-02-24T17:31:27Z | E9-03831 | 0 | 0 | 09000064808d6e38 | |
| FDA-2009-N-0665-0001 | FDA | FDA-2009-N-0665 | New Animal Drugs: Bc6 Recombinant Deoxyribonucleic Acid Construct | Rule | NFR-Notice of Final Rule | 2009-02-11T05:00:00Z | 2009 | 2 | 2009-02-11T05:00:00Z | 2009-02-11T20:28:59Z | E9-02881 | 0 | 0 | 0900006480852428 | |
| FDA-2008-N-0341-0005 | FDA | FDA-2008-N-0341 | Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports: Reporting Information about Authorized Generic Drugs; Withdrawal | Rule | NWL-Notice of Withdrawl | 2009-02-10T05:00:00Z | 2009 | 2 | 2009-02-10T05:00:00Z | 2009-02-10T20:16:46Z | E9-02746 | 0 | 0 | 090000648084f5c8 | |
| FDA-2008-N-0039-0095 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs: Ivermectin Paste - Final Rule | Rule | Final Rule | 2009-02-10T05:00:00Z | 2009 | 2 | 2009-02-10T05:00:00Z | 2014-01-08T14:11:50Z | E9-02749 | 0 | 0 | 090000648084f677 | |
| FDA-1982-N-0010-0007 | FDA | Vitamin D2 & D3 Proposed Affirmation of GRAS Status FDA-1982-N-0010 | Vitamin D2 & D3 Proposed Affirmation of GRAS Status; with Specific Limitations as Direct Human Food Ingredients | Rule | NFR-Notice of Final Rule | 2009-01-21T05:00:00Z | 2009 | 1 | 2009-01-21T05:00:00Z | 2009-01-22T00:41:41Z | 0 | 0 | 0900006480829bdf | ||
| FDA-2008-N-0039-0094 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs: Phenylbutazone Tablets and Boluses | Rule | Final Rule | 2009-01-12T05:00:00Z | 2009 | 1 | 2009-01-12T05:00:00Z | 2013-07-09T19:32:23Z | E9-00265 | 0 | 0 | 090000648081b72e | |
| FDA-1998-P-0032-0002 | FDA | Prohibition of Cochineal Extract and Carmine Color Additives - CLOSED FDA-1998-P-0032 | Listing of Color Additives Exempt From Certification; Food, Drug, and Cosmetic Labeling: Cochineal Extract and Carmine Declaration | Rule | Final Rule | 2009-01-05T05:00:00Z | 2009 | 1 | 2009-01-05T05:00:00Z | 2009-02-05T04:59:59Z | 2024-11-12T04:34:59Z | 1 | 0 | 090000648080f0f8 | |
| FDA-2008-N-0517-0001 | FDA | FDA-2008-N-0517 | Medical, Immunology and Microbiology Devices: Classification of Enterovirus Nucleic Acid Assay | Rule | NFR-Notice of Final Rule | 2009-01-02T05:00:00Z | 2009 | 1 | 2009-01-02T05:00:00Z | 2009-01-09T03:28:05Z | E8-31213 | 0 | 0 | 090000648080c365 | |
| FDA-2008-N-0039-0093 | FDA | FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Tiamulin | Rule | Final Rule | 2009-01-02T05:00:00Z | 2009 | 1 | 2009-01-02T05:00:00Z | 2013-07-09T19:38:10Z | E8-31128 | 0 | 0 | 090000648080c33b |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);